Ruby Nanomed

Palestinian Territories
Al Buwayrah, West Bank, Palestinian Territory, 4715-330

Company profile

Ruby Nanomed company profile

RUBYnanomed provides non-invasive monitoring of cancer progression. They enable the analysis of their phenotypic, genetic, and functional characteristics, facilitating unprecedentedly frequent monitoring of cancer progression in a minimally invasive, cost-efficient way. They enable oncologists to detect and analyze the evolution of cancer subtypes and therapeutic resistance mechanisms in each patient, providing personalized therapy insights to treat their patients.

Business identity

Contact email
[email protected]
Phone number
+351 253 654 985
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2018-01-01, Year

Headquarters

Postal code
4715-330
Country code
PS
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$119,113
Last funding
Seed / 2023-08-24
Last equity funding
Seed
Investors
2
Lead investors
1
Founders
3

Categories and groups

Founders and investors

Founders

Lorena DiéguezPaulina PiairoSara Abalde

Lead investors

European Innovation Council

Investors

European Innovation CouncilPortugal Ventures